Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample
CA 2392469 A1 · Owner: Diasorin Srl · Inventors: Reinhartz, Avraham; Alajem, Sara; Waksman, Michal
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An oligonucleotide or assembly of oligonucleotides for the detection of the presence or absence of a target nucleic acid in a sample. The assembly of oligonucleotides comprises four regions a first and second regions which , hybridize to the target nucleic acid sequence and a third and fourth region where the third region is linked to the first region and the second region is linked to the fourth region. The third and fourth regions hybridize to one another. This hybridized structure can be cleaved with a restriction enzyme which cleavage will indicate hybridization of the oligonucleotide or oligonucleotides to the target. The invention also comprises methods of using these …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 29, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 29, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.